(Q38721726)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

review article

1 reference

title

Peroxisome Proliferator-Activated Receptor Ligands and Their Role in Chronic Myeloid Leukemia: Therapeutic Strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

main subject

chronic myeloid leukemia

0 references

author

Bahman Yousefi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Nasser Samadi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Behzad Baradaran

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Vahid Shafie-Irannejad

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Nosratollah Zarghami

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Bahman Yousefi

1

1 reference

5 September 2017

Nasser Samadi

2

1 reference

5 September 2017

Behzad Baradaran

3

1 reference

5 September 2017

Vahid Shafiei-Irannejad

4

1 reference

5 September 2017

Nosratollah Zarghami

5

1 reference

5 September 2017

publication date

6 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

Chemical Biology and Drug Design

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

17-25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Targeted drugs in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

An overview on biological mechanisms of PPARs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Peroxisome proliferator activated receptor α ligands as anticancer drugs targeting mitochondrial metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Mechanism of the nuclear receptor molecular switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Peroxisome proliferator-activated receptors and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

PPARs: therapeutic targets for metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Metabolic and additional vascular effects of thiazolidinediones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

The role of PPARs in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Activation of PPARdelta alters lipid metabolism in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Peroxisome-proliferator-activated receptors and cancers: complex stories

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

The Role of PPARs in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

PPAR Ligands for Cancer Chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Biology of PPAR gamma in cancer: a critical review on existing lacunae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

APC-dependent suppression of colon carcinogenesis by PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

The PPARγ agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Troglitazone activates p21Cip/WAF1 through the ERK pathway in HCT15 human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Activation of multiple mitogen-activated protein kinases in pro/pre-B cells by GW7845, a peroxisome proliferator-activated receptor gamma agonist, and their contribution to GW7845-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Peroxisome Proliferator-Activated Receptor γ and Retinoic Acid Receptor Synergistically Up-Regulate the Tumor Suppressor PTEN in Human Promyeloid Leukemia Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

PPAR gamma signaling exacerbates mammary gland tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Emerging concepts in metabolic abnormalities associated with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Therapeutic potential of thiazolidinediones as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

PPARgamma: observations in the hematopoietic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Induction of erythroid differentiation in the human leukaemia cell line K562.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 product

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Dual PPARalpha/gamma ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone--induced apoptosis in leukemia k562 cells and its mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

What are caspases 3 and 7 doing upstream of the mitochondria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Apoptosis-associated caspase activation assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Activation of p65 NF-kappaB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARalpha/gamma ligand TZD18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Akt and p53R2, partners that dictate the progression and invasiveness of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12737

21 January 2018

Identifiers

DOI

10.1111/CBDD.12737

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26841308%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference